In-Hospital Disease Progression in Moderate to Severe Chronic Kidney Disease Patients with COVID-19 Treated with Nirmatrelvir/Ritonavir is a research paper published in Journal of General Internal Medicine (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: UL1TR002548
National Institutes of Health
Grant: 3UL1TR002548-03S1
Clinical and Translational Science Collaborative of Cleveland
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
Keywords
Sustainable Development Goals